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Abstract
Bile salts are secreted into the gastrointestinal tract to aid in the
absorption of lipids. In addition, bile salts show potent antimicro-
bial activity in part by mediating bacterial protein unfolding and
aggregation. Here, using a protein folding sensor, we made the
surprising discovery that the Escherichia coli periplasmic glycerol-
3-phosphate (G3P)-binding protein UgpB can serve, in the absence
of its substrate, as a potent molecular chaperone that exhibits
anti-aggregation activity against bile salt-induced protein aggre-
gation. The substrate G3P, which is known to accumulate in the
later compartments of the digestive system, triggers a functional
switch between UgpB’s activity as a molecular chaperone and its
activity as a G3P transporter. A UgpB mutant unable to bind G3P is
constitutively active as a chaperone, and its crystal structure
shows that it contains a deep surface groove absent in the G3P-
bound wild-type UgpB. Our work illustrates how evolution may be
able to convert threats into signals that first activate and then
inactivate a chaperone at the protein level in a manner that
bypasses the need for ATP.
Keywords chaperone; protein folding
Subject Category Translation & Protein Quality
DOI 10.15252/embj.2019104231 | Received 9 December 2019 | Revised 12 July
2020 | Accepted 17 July 2020 | Published online 3 September 2020
The EMBO Journal (2020) 39: e104231
Introduction
Proteins are key catalysts for most cellular processes, and maintain-
ing protein stability is an important and regulated process (Balch
et al, 2008). When enteric bacteria pass through the gastrointestinal
tract, the bacteria encounter various host defense barriers that target
protein stability, including gastric acid in the stomach and bile in
the duodenum, both of which act to denature proteins (Baba et al,
2006; Cremers et al, 2014). Periplasmic proteins are particularly
vulnerable to these environmental denaturants because the outer
membrane of the cell allows for the free diffusion of small molecules
(Baba et al, 2006). It is known that bacteria have evolved acid-
response periplasmic chaperones, HdeA and HdeB, to protect cells
from acid-induced protein aggregation in the periplasm (Tapley
et al, 2010; Dahl et al, 2015; Lai et al, 2017). However, surprisingly
little is known about how bacteria respond to the denaturant proper-
ties of bile salts.
Bile salts are amphipathic compounds that not only help in the
absorption of lipids in the intestine (Heaton, 1969; Gunn, 2000;
Urdaneta & Casadesus, 2017), but also possess potent antimicrobial
activity (Urdaneta & Casadesus, 2017), which is elicited by disrupt-
ing cell membranes, inducing DNA damage, and causing protein
unfolding and aggregation (Prieto et al, 2004; Merritt & Donaldson,
2009; Cremers et al, 2014; Urdaneta & Casadesus, 2017). It is known
that bile salts can achieve limited entry into the bacterial cytosol
through a flip-flop mechanism (Cabral et al, 1987) and that various
chaperones, including Hsp33, DnaK, and GroEL, are upregulated in
response to their cytosolic unfolding activity, but it is unclear if or
how these chaperones act to protect proteins from the denaturing
effects of bile (Flahaut et al, 1996; Bernstein et al, 1999; Leverrier
et al, 2003; Ruiz et al, 2013; Cremers et al, 2014). Although the
bacterial periplasm presumably has a much higher exposure to bile
salts than the cytosol, remarkably little is known about how
periplasmic proteins are protected against bile salts.
Here, we employed high-throughput transposon sequencing (Tn-
Seq) combined with a periplasmic protein folding sensor (Foit et al,
2009; van Opijnen et al, 2009), which links protein stability to
antibiotic resistance, to screen for host factors that affect periplas-
mic protein folding. We find that the glycerol-3-phosphate (G3P)-
binding protein UgpB has a second function, namely moonlighting
as a chaperone that appears to be uniquely capable of preventing
bile-induced aggregation of a wide variety of proteins present in the
periplasm. UgpB alternates between its function as a chaperone and
as a G3P-binding protein, with its activity being controlled by small
molecules known to be present in the intestine. We find UgpB’s
chaperone activity is inhibited upon binding to its normal substrate
G3P, which can be stripped off by pH conditions present in the
stomach. A variant of UgpB that fails to bind G3P is constitutively
active as a chaperone and newly possesses a binding groove on the
surface of its structure deep enough to accommodate peptides. This
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toggling of UgpB activity by small molecules is consistent with a
model in which UgpB acts as a chaperone to guard against bile-
mediated aggregation early in digestion and then switches to its role
as a G3P-binding protein later in digestion, a switch that may be
mediated at least in part by rising G3P concentrations caused by
digestion.
Results
Use of Tn-Seq and a protein folding sensor in
chaperone discovery
In efforts to discover previously uncharacterized chaperones in the
periplasm of E. coli, we combined an in vivo selection for improved
protein folding with a Tn-Seq approach. Tn-Seq is a high-throughput
method that allows one to compare the frequencies of transposon
insertion in essentially all genes between two populations, one of
which has been subject to a genetic selection (van Opijnen et al,
2009; Burby et al, 2017). Genes that, when disrupted, produce
either better or worse growth under the applied selection conditions
can thus be identified and subsequently characterized. The selection
that we used in this approach is based on the expression of a folding
biosensor, whose in vivo stabilization is directly linked to increased
antibiotic resistance. This selection, in conjunction with Tn-Seq,
provides a facile way of screening the whole genome of E. coli for
genes that affect the folding of sensor protein. The folding biosensor
that we used contains Im7 L53A I54A inserted into a glycine–serine
linker between positions 196 and 197 of b-lactamase, a protein that
confers ampicillin resistance (Fig 1A and Appendix Fig S1A; Foit
et al, 2009; Quan et al, 2011). Im7 L53A I54A is an unstable and
partially unfolded variant of Im7 that mimics the intermediate that
accumulates in Im7’s folding pathway (Quan et al, 2013). We
reasoned that host mutations that stabilize the test protein should
increase the ampicillin resistance of strains containing this folding
biosensor, whereas those that destabilize the test protein should
decrease their ampicillin resistance. Hence in our screen (illustrated
in Fig 1A, see Materials and Methods for details), we focused in
genes that showed an altered transposon insertion frequency after
antibiotic resistance selection in strains that contained the tripartite
folding sensor relative to a control strain that just contained the
intact unfused b-lactamase gene (bla). We reasoned that genes that
showed an altered insertion frequency in the folding biosensor
strain might be involved in folding or stabilizing the biosensor.
Validation of Tn-Seq use for chaperone discovery
In our previous study, we discovered the periplasmic chaperone Spy
by isolating mutants that enhanced the stability of Im7 L53A I54A
(Quan et al, 2011). As described in Fig EV1, we were able to show
that the transposon insertion frequencies in spy as well as in baeSR
encoding a transcriptional regulator for Spy are dramatically
decreased when cells are subject to ampicillin a selection. Thus, we
were able to re-isolate Spy mutants by their decreased chaperone
activity as well as the transcription factor that controls this chaper-
one’s expression with this Tn-Seq approach. With these results serv-
ing as evidence that our genetic strategy is working as intended, we
decided to expand our search for genes with altered insertion
frequencies in the wild-type strain containing the Im7 L53A I54A
tripartite versus one containing the pBR322 control. The lack of
expression of Spy in wild-type strains conveniently allows us to use
this genetic approach to search for chaperones or folding factors, in
addition to Spy, that affect the stability of Im7.
PstSCA insertions answer selections conducted in folding sensor
containing strains
To find genes that may contribute to the folding or stability of the
test protein Im7, we identified loci that show an altered transposon
insertion frequency in the strain encoding the protein folding sensor
b-lactamase-Im7 L53A I54A relative to the strain containing the
intact b-lactamase encoded by pBR322. Use of the pBR322 control
allowed us to exclude genes that contribute to ampicillin resistance
for reasons unrelated to the expression, folding, or stability of the
test protein. Since both the sensor and the intact b-lactamase genes
are under the same transcriptional, translational, and plasmid copy
number control, we reasoned that genes affecting these processes
will not show a differential insertion frequency between the two
strains. Genes involved in ampicillin resistance itself should be
disrupted at approximately equal rates in strains containing the
intact bla gene versus tripartite fusions derived from the bla gene.
One locus that showed a highly elevated transposon insertion
frequency in the biosensor strain relative to the control encoded the
pstSCA genes (Fig 1B). PstSCA encodes an ATP-binding cassette
(ABC) transporter for phosphate uptake (Gardner et al, 2015). To
confirm that insertions within pstSCA genes were able to specifically
enhance ampicillin resistance of strains containing the Im7 folding
biosensor, we transduced deletion mutants of the individual pst
genes into the biosensor strains and into control strains containing
only the intact b-lactamase gene and then tested for ampicillin resis-
tance (Fig 2A). Deletions of, or transposon (Tn5) insertions into the
pstS, pstC, or pstA genes substantially increased ampicillin resis-
tance in the presence of b-lactamase-Im7 L53A I54A, but did not
enhance resistance of strains containing intact b-lactamase or b-
lactamase-linker constructs (Fig 2A, Appendix Figs S1A and S2).
These results suggested that the pstSCA genes were good candidates
for genes involved either directly or indirectly in the stability of the
protein folding biosensor and thus were worthy of further analysis.
PstSCA mutants result in increased levels of the protein folding
sensor in vivo
As measured by Western blotting, the protein level of the Im7 fold-
ing biosensor is ~14-fold lower than levels of intact b-lactamase
found in wild-type strains. As we found previously (Quan et al,
2011), this is presumably again due to protein instability conferred
by the Im7 portion of this folding biosensor. Tn5 insertions in the
pstS, pstC, or pstA genes resulted in a 2- to 4-fold increase in the
levels of the b-lactamase-Im7 L53A I54A folding biosensor, but no
change in the levels of intact b-lactamase (Fig 2B). Moreover, the b-
lactamase activity contained in periplasmic cell extracts from cells
expressing the folding biosensor was 4- to 5-fold higher in the pstS,
pstC, or pstA mutants than it was in strains that are wild-type for
the pst locus (Fig 2C). These results suggested that we may have
indeed identified genes involved in determining the stability and/or
expression of the folding biosensor.
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Figure 1. Genetic screening using Tn-Seq and a protein folding sensor.
A As a protein folding sensor, we constructed a tripartite fusion protein in which the test protein (shown in blue) is inserted between the N-terminal portion of the
selectable marker, b-lactamase (shown in pink), and the C-terminal portion of b-lactamase (shown in peach). Instability of the test protein leads to either degradation
or aggregation, resulting in lower ampicillin resistance (AmpS) of strains containing this biosensor compared to those in which the test protein is stable. If a host
factor or chaperone stabilizes the test protein, higher levels of ampicillin resistance (AmpR) will be exhibited. First, we generated a transposon (Tn) library in strains
containing either a protein folding sensor or a b-lactamase glycine–serine linker construct (see Materials and Methods for details). Secondly, ampicillin resistance
selections were performed, and colonies resistant to various levels of ampicillin were pooled and subjected to deep sequencing. This enabled the genomic mapping of
the position and frequency of transposon insertion sites. Genes showing an altered transposon insertion frequency in the presence of a protein folding sensor were
selected as candidates for host factors that affect the stability of that protein folding sensor. See also Appendix Fig S1A.
B When transposon insertion libraries subjected to ampicillin resistance selection, a substantial increase in transposon insertion frequency in the pstSCA genes was
observed in strains containing the protein folding sensor (pBR322 bla::Im7 L53A I54A) relative to a strain containing just pBR322. Transposon insertion frequency
increased 21-, 24-, and 8-fold in the pstS, pstA, and pstC genes, respectively, compared to the insertion frequency found with no ampicillin selection.
ª 2020 The Authors The EMBO Journal 39: e104231 | 2020 3 of 17
Changhan Lee et al The EMBO Journal
To test if the effect of the pst mutants on the folding biosensor
extended to the Im7 protein itself, we expressed Im7 and Im7
L53AI54A proteins on their own, in the absence of the fusion
context. Enhancement of Im7 L53A I54A levels was observed in the
pstS and pstA mutant strains was indeed observed (Fig 2D and
Appendix Fig S3). Wild-type Im7, which is well folded and stable
compared to the Im7 L53A I54A variant, was expressed at a very
similar level in wild-type and pstS mutant strains (Appendix Fig S3).
This is consistent with our observation that pst mutants do not
significantly enhance ampicillin resistance in the presence of b-lacta-
mase-Im7 (Appendix Figs S2A and S3A). These results provided a
preliminary indication that the pstSCA mutations are able to stabi-
lize Im7 L53A I54A in vivo.
UgpB acts to enhance the protein level of Im7 L53A I54A
Our studies showed that mutants lacking components of the Pst
machinery accumulate higher levels of folded Im7 L53A I54A than
A
B C D
Figure 2. Deletion mutants in the pstSCA genes act to stabilize the b-lactamase-Im7 L53A I54A folding biosensor and the Im7 L53A I54A protein Itself In vivo.
A To verify that disruption of the pst genes is sufficient to increase ampicillin resistance of strains containing the pBR322 bla::Im7 L53A I54A folding biosensor and to
test which of the genes in the pst operon are sufficient for this effect, pBR322 and pBR322 bla::Im7 L53A I54A were transformed into strains containing in-frame
deletion mutants of each of the pst genes (pstS, pstC, and pstA, respectively). The deletion mutants of each of these pst genes showed higher ampicillin resistance
than did the wild-type strain MG1655 in the presence of pBR322 bla::Im7 L53A I54A, but did not show higher ampicillin resistance in the presence of pBR322. See also
Appendix Fig S2A.
B Levels of b-lactamase (Bla) and b-lactamase-Im7 L53A I54A were detected by Western blotting using a polyclonal antibody recognizing b-lactamase in the wild-type
strain MG1655 and in isogenic strains containing Tn5 insertions in the pstSCA genes (CL248 (pstS::Tn5), CL249 (pstC::Tn5), CL250 (pstA::Tn5)). Maltose-binding protein
(MBP) was used as a control.
C b-lactamase enzymatic activities present in periplasmic extracts of the Im7 folding biosensor were monitored in pst wild-type and pstSCA mutant strains using a
spectrophotometric assay. Data are represented as mean  SEM from three technical replicates (unpaired t-test, **P < 0.01, ***P < 0.001 comparison to MG1655; ns,
not significant).
D To test if levels of the Im7 L53A I54A protein itself, in the absence of the fusion, were also higher in the pstA mutant, expression of the Im7 L53A I54A protein from the
IPTG-inducible plasmid pCDFTrc was induced using IPTG concentrations ranging from 0 to 5 mM. Periplasmic fractions were isolated and examined by SDS–PAGE
and subsequent Coomassie staining to determine overall protein expression patterns. Im7 L53A I54A levels were determined by Western blotting using an antibody
for Im7. MBP was used as a loading control. Im7 L53A I54A was increased in the pstA strain relative to the wild-type control strain. Coomassie staining revealed that a
number of periplasmic proteins, including UgpB, were also induced in the pstA strain.
Data information: These experiments were repeated twice with similar results, and one representative is shown.
Source data are available online for this figure.
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wild-type E. coli strains. Since it is known that disruption of pst
genes substantially affects the expression of a number of diverse
genes (Crepin et al, 2008), we wondered whether the observed
effects were a direct or indirect effect on protein expression, folding,
and/or stability. We therefore considered the possibility that pst
disruption increases the expression of some other proteins that then
more directly act to stabilize the protein folding sensor. To investi-
gate this, we performed liquid chromatography–mass spectrometry
to quantify the levels of proteins present in whole cell lysates of
strains containing pst disruptions. As previously observed (Crepin
et al, 2008), a wide variety of phosphate transportation-related
proteins were overexpressed in pst mutant strains (Dataset EV1).
We selected six of these overexpressed proteins as candidates
(PhoA, PhoE, PhnD, UgpB, DsbC, and FkpA) based on two criteria:
(i) periplasmic localization, since b-lactamase is expressed and
active in the periplasm, and (ii) expression levels, since proteins can
be stabilized by chaperone overexpression or protease depletion.
Given our interest in chaperone discovery, we selected proteins that
are present at higher levels (> 2-fold) in the pst mutants as
compared to wild-type strains.
To test if the overabundance of these candidate proteins was
directly responsible for the apparent stabilization of the Im7 L53A
I54A folding sensor in a pst deletion background, we co-deleted
them from a pstS null strain and determined if the ampicillin pheno-
type linked to the stabilization of the biosensor simultaneously
disappeared. We found that additional deletion of phoA, phoE,
phnD, dsbC, or fkpA deletions had no effect on the ampicillin resis-
tance encoded by the Im7 L53A I54A folding biosensor
(Appendix Fig S4), implying that these five genes were not responsi-
ble for the accumulation of Im7 observed in pst mutants. However,
introducing a ugpB deletion into a pstS or pstA null mutant made
these cells just as ampicillin sensitive as did a pstS+ or pstA+ strain
background (Fig 3A, Appendix Figs S4 and S5). UgpB deletions in
the pst null mutant specifically affected the ampicillin resistance of
the destabilized b-lactamase-Im7 L53A I54A folding biosensor, but
did not affect the ampicillin resistance of any of the other b-lacta-
mase constructs, b-lactamase itself, b-lactamase containing a 33
amino acid glycine–serine linker, or b-lactamase-Im7, all which
encode more stable proteins (Fig 3A and Appendix Fig S5). Taken
together, these observations indicate that the UgpB overexpression
induced by the pst deletion is most likely directly responsible for
specifically enhancing ampicillin resistance through its ability to
stabilize the Im7 L53A I54A protein folding sensor.
These observations are surprising, as UgpB’s only known activity
to date is its ability to function as a periplasmic glycerol-3-phos-
phate (G3P)-binding protein that functions in G3P transport (Wuttge
et al, 2012). Chaperones tend to be very abundant proteins (Yan
et al, 2019), so it is interesting to note that based on our proteome
analysis in the pstS or pstA mutants, UgpB was induced > 16-fold
(Dataset EV1), to very high levels, similar to levels of UgpB overex-
pression that had been previously reported in pst mutant strains
(Crepin et al, 2008). This level of overexpression makes UgpB the
most abundant protein present in periplasmic extracts of pstS or
pstA mutants, (Fig 2D, Appendix Figs S3 and S6). To test whether
overexpression of UgpB is sufficient to enhance b-lactamase-Im7
L53A I54A levels, we expressed UgpB from an arabinose-inducible
promoter in a ugpB deletion mutant. We found that this overexpres-
sion confers as high a level of ampicillin resistance as is present in
pst mutations, implying that UgpB overexpression is responsible for
the enhanced ampicillin resistance seen in the pst mutations
(Fig 3B). Overexpression of UgpB also leads to accumulation of Im7
L53A I54A itself, independent of it being present in a fusion context
(Fig 3C). We conclude that UgpB overexpression is sufficient to
cause in vivo accumulation of stably folded Im7 L53A I54A.
UgpB prevents bile salt-induced protein aggregation
To analyze whether UgpB has a general chaperone activity, we
tested its influence on classic chaperone substrates using light scat-
tering measurements. We found that UgpB does not interfere with
the heat-induced aggregation of the classic chaperone substrates
malate dehydrogenase (MDH), citrate synthase (CS), or luciferase.
These results make physiological sense since periplasmic proteins
tend to be very thermostable, likely eliminating the need for chaper-
ones to protect them from heat-induced aggregation. In searching
for a possibly more physiologically relevant stressor, we noted that
UgpB expression is highly induced upon bile stress in Salmonella
enterica and that a ugpB deletion mutant of E. coli shows high sensi-
tivity to bile salts (Nichols et al, 2011; Hernandez et al, 2012). Bile
salts are amphipathic compounds that help in the absorption of
lipids in the intestine (Urdaneta & Casadesus, 2017). They are also
well known for their antimicrobial activity and are particularly
potent against Gram-positive bacteria (Urdaneta & Casadesus,
2017). Although not as well publicized, bile salts also act as deter-
gents, causing protein unfolding and aggregation (Cremers et al,
2014). We confirmed that the disruption of ugpB in the E. coli BL21
(DE3) strain slightly increases the susceptibility of the mutant to bile
salts and demonstrated that the overexpression of UgpB from the
pTrc99a plasmid under the IPTG-inducible promoter confers a
significantly increased resistance to cholate (CHO), the most preva-
lent primary bile salt in the human intestine, particularly at elevated
temperatures (Fig 4A). Since bile salts directly unfold and aggregate
proteins (Cremers et al, 2014; Urdaneta & Casadesus, 2017), we
examined whether UgpB can prevent bile salt-induced protein aggre-
gation in vitro. We used MDH, lactate dehydrogenase (LDH), and
CS as model substrates and induced their aggregation by treatment
with CHO. We monitored protein aggregation by light scattering or
analyzing protein solubility (Fig 4B and C; Materials and Methods).
Addition of CHO induces the aggregation of MDH, LDH, and CS
(Figs 4B and C, and EV2, and Appendix Fig S10). Notably, UgpB
efficiently prevents CHO-induced aggregation of all three of these
proteins in a dose-dependent manner. UgpB also shows potent anti-
aggregation activity toward the CHO-induced aggregation of total
E. coli lysates (Fig 4F). Our results suggest that UgpB does function
as a molecular chaperone, with a surprisingly broad substrate
spectrum, that is capable of preventing bile salt-induced protein
aggregation.
Since chaperones often exhibit functional redundancy, we
decided to investigate whether other periplasmic chaperones also
display anti-aggregation activity in response to CHO-induced protein
aggregation. Spy, SurA, and OsmY are known periplasmic chaper-
ones (Ruiz et al, 2013; Stull et al, 2018). SurA is involved in main-
taining the solubility of outer membrane proteins while they are in
transit through the periplasmic space (Stull et al, 2018). Spy is a
stress-inducible chaperone that prevents stress-induced protein
aggregation and assists in the folding of its clients (Quan et al,
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2011). OsmY exhibits anti-aggregation activity and is induced by
bile salt treatment (Hernandez et al, 2012; Lennon et al, 2015).
These other chaperones are inactive in preventing CHO-induced
protein aggregation using the model substrate MDH, at least under
the conditions tested (Fig 4D), providing evidence that UgpB’s anti-
aggregation activity in response to bile salt stress is unique.
The anti-aggregation activity of UgpB is regulated by binding
to G3P
Since UgpB can be present as either G3P-free apo or G3P-bound
holo forms depending on the environmental conditions to which
cells are exposed, we compared the chaperone activity of
G3P-bound form (hereafter referred to as UgpBG3P) and G3P-free
UgpB. We found that the anti-aggregation activity of UgpB is
strongly modulated by the presence G3P. After expression of UgpB
in the cytoplasm and subsequent purification, UgpB is almost
entirely G3P bound. The observed G3P occupancy is 90% likely
because G3P, as a key glycolysis intermediate (Appendix Figs S7–
S9), is abundant in cytoplasm (Lemieux et al, 2004). These G3P-
bound UgpB preparations show roughly 10-fold lower anti-aggrega-
tion activities than G3P-free UgpB that has had its G3P stripped off
by dialysis performed in the presence of denaturant followed by
protein refolding (Fig EV2). In agreement with this, addition of G3P
A
B C
Figure 3. UgpB confers high ampicillin resistance to strains containing the Im7 L53A I54A protein folding sensor.
A MG1655 wild-type, single mutants of pstA and ugpB, and a double mutant of pstA ugpB were transformed with pBR322 and various pBR322-based folding biosensor
constructs. The transformants were examined by a spot titer assay on LB agar plates containing various ampicillin concentrations. Strains containing pBR322 bla::Im7
L53A I54A gain considerable ampicillin resistance in the presence of a pstA mutation (compare uppermost left and right panels). This resistance is completely lost
upon transducing in a ugpB mutation (compare next panels down), showing that ugpB is responsible for the resistance gained by the pstA mutation.
B Ampicillin sensitivity conferred by a ugpB deletion mutant (CL543) is complemented by UgpB expression from the arabinose-inducible expression vector pBAD33 ugpB (pCL1).
C UgpB expression is sufficient to lead to higher levels of Im7 L53A I54A protein. Im7 L53A I54A and UgpB were expressed in a ugpB mutant strain (CL543) from pCDFTrc
and pTrc99a vectors, respectively, both of which have an IPTG-inducible promoter. Periplasmic fractions were isolated and examined by Western blotting. “”
indicates strains containing empty vector, and “+” indicates strains containing a recombinant plasmid encoding either Im7 L53A I54A or UgpB. MBP was used as a
loading control.
Data information: These experiments were repeated twice with similar results, and one representative is shown.
Source data are available online for this figure.
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inhibits UgpB’s chaperone function (Fig 4E and F, and Appendix Fig
S10). UgpB is present in the periplasm of bacteria, for its chaperone
activity to make physiological sense, and for the genetic selection
for chaperone activity to have succeeded, periplasmic UgpB should
be at least partially G3P free. UgpB in periplasmic extracts was
determined by absorption experiments to have only 36% G3P occu-
pancy (Appendix Fig S9E). Since some G3P may be released from
the cytosol during the periplasmic extraction procedure, this likely
represents the upper limit for G3P occupancy in the periplasm
in vivo. These results suggest that the active chaperone form of
UgpB is present in vivo and is thus likely involved in the stabiliza-
tion of protein folding sensor.
To obtain additional evidence that release of G3P activates the
chaperone activity of UgpB, we tested the chaperone activity of two
variants (W169S and W169S/W172S), which are known to be defec-
tive in binding G3P (Wuttge et al, 2012). If activation of chaperone
activity is due to G3P release, we reasoned that these variants
should be constitutively chaperone active, independently of the
presence or absence of G3P. Indeed, we observed that G3P did not
diminish the anti-aggregation activity of both of these G3P defective
variants, while the activity of wild-type UgpB is completely abol-
ished in the presence of G3P (Figs 4G and H). Notably, both vari-
ants exhibit lower anti-aggregation activity than does the wild-type
UgpB, suggesting that the tryptophan residues W169 and W172 are
involved not only in G3P binding but also in the anti-aggregation
activity of UgpB.
The substitution of the two tryptophan residues likely affects the
chaperone activity of UgpB in two ways, first by making UgpB
constitutively chaperone active because these tryptophan residues
are involved in G3P binding but second since these hydrophobic
residues are also likely to be involved in peptide binding, these
substitutions are also likely to decrease the chaperone activity. To
distinguish between these effects, we attempted to isolate the UgpB
variants that are only defective in G3P binding and are not likely to
be directly involved in peptide binding. We selected glutamate 66
and arginine 374 and substituted them with alanine and valine,
respectively. These two residues contain charged side chains that
are directly involved in G3P binding (Wuttge et al, 2012; Fenn et al,
2019). We found that the E66A and R374V variants of UgpB exhibit
the same of chaperone activity as does the G3P-free form of wild-
type UgpB; i.e., they are constitutively chaperone active (Fig 4I and
J). Importantly, in contrast to wild-type UgpB, the chaperone activ-
ity of these UgpB variants is not negatively affected in the presence
of G3P (Fig 4I and J). These constitutively chaperone active mutants
strongly support our hypothesis that G3P binding is a switch that
modulates the chaperone activity of UgpB.
Release of G3P opens up a deep groove on the surface of
UpgB’s structure
To gain more structural insights into the mechanism of G3P-regu-
lated UgpB’s chaperone activity, we decided to crystallize and
determine the structure of chaperone active, G3P-free UgpB. We
were unsuccessful in crystallizing apo wild-type UgpB, possibly
because the process of stripping G3P involves denaturation and
refolding which may interfere with crystallization. However,
attempts to crystallize a G3P-binding defective variant (W169S/
W172S) were successful and we solved its structure to 1.25 Å
resolution (Appendix Table S3). The overall structure of this
UgpB variant adopts a more open conformation than the G3P-
bound structure does, very similar to what is known about the
differences in structure between apo and holo UgpB from
Mycobacterium tuberculosis (Fenn et al, 2019; Appendix Fig S11).
Since the W169S/W172S variant of E. coli UgpB shows no detect-
able ability to bind G3P (Wuttge et al, 2012), we reasoned that
its crystal structure should mimic the conformation of apo wild-
type UgpB. To even better mimic ligand-free wild-type UgpB, we
constructed a structure model using the SWISS-MODEL program
of the wild-type UgpB structure by reverting the W169S/W172S
mutations to their native tryptophans. While some local regions
▸Figure 4. UgpB prevents bile-Induced protein aggregation.A UgpB overexpression confers resistance to the bile salt CHO, and a ugpB deletion mutant is slightly CHO sensitive.
B CHO-induced MDH protein aggregation analyzed by monitoring light scattering.
C CHO-induced MDH protein aggregation analyzed by a solubility assay using centrifugation (cfg) at 16,000 g for 20 min. The supernatant (Sup) represents the soluble
fraction and the pellet the insoluble fraction; 12 lM MDH was used as a model aggregation-prone substrate (see Materials and Methods). Addition of increasing
quantities of UgpB increasingly solubilizes MDH. The molar ratios of MDH:UgpB that were used (left to right) are as follows: 1:0, 1:0.1, 1:0.2, 1:0.5, and 1:1. 5-fold more
of the pellet fraction was loaded relative to the supernatant fraction.
D The supernatant/pellet assay was performed using a 1:1 MDH:chaperone ratio for Spy, SurA, and OsmY. The pellet fraction was concentrated 5-fold.
E 12 lM of MDH alone and a 1:1 ratio of either MDH:UgpB or MDH:MBP were incubated at 37°C for 60 min in the presence of CHO and then fractionated via
centrifugation for use in a solubility assay as described above (C). The pellet fraction was concentrated 5-fold. In some samples (+G3P), 120 lM of G3P was added
prior to the addition of any other protein. Addition of G3P inactivates UgpB’s ability to inhibit protein aggregation.
F 800 lg of E. coli total lysate and 60 lM of UgpB/MBP were used for the supernatant/pellet assay. 600 lM of G3P was added before adding proteins. The pellet
fraction was concentrated 10-fold. As before, addition of UgpB inhibited aggregation, but only in the absence of G3P.
G The anti-aggregation activity of tryptophan single mutant (W169S) and double mutant (W169S/W172S) was examined by CHO-induced MDH aggregation assay. Light
scattering values were monitored.
H Solubility of MDH is also monitored by supernatant/pellet assay. Tryptophan mutants exhibit constitutively active chaperone function independent of the presence of
G3P. The pellet fraction was concentrated 5-fold. 12 lM of MDH and 1:1 ratio of MDH:UgpB proteins and 120 lM of G3P were used.
I The anti-aggregation activity of the UgpB variants (E66A and R374V) was examined by CHO-induced MDH aggregation assay. CHO-induced MDH protein aggregation
analyzed by monitoring light scattering.
J Solubility of MDH is also monitored by supernatant/pellet assay. 12 lM of MDH alone, a 1:1 ratio of MDH:UgpB proteins, and 120 lM of G3P were used.
Data information: These experiments were repeated at least twice with similar results, and one representative is shown. 15 mM CHO was used for all the aggregation
and supernatant/pellet assays.
Source data are available online for this figure.
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A
B
Figure 5. Structural analysis of G3P-regulated conformational change.
A Stereoview of a superposition the structure of apo form of UgpB (blue) and the G3P-bound form of UgpB (orange; pdb: 4aq4) is shown. The apo form of UgpB was
modeled by SWISS-MODEL program using the 1.25 Å crystal structure of the non-G3P binding W169S, W172S variant of UgpB as a template. The C-terminal domains
(residues 123–281 and 360–415) of apo UgpB and G3P-bound UgpB were superimposed to illustrate the G3P-induced repositioning of a domain relative to the other.
B G3P-bound form exists in a closed conformation, and the G3P-binding site is buried in between the two domains (left). Apo form adopts an open conformation and
exposes a cleft in the domain interface (right). The surface of UgpB is colored cyan, and a continuous groove that buried in closed form but exposed in the open
conformation is highlighted according to the characteristics of residues (green, hydrophobic residues; orange, polar residues; blue, positive-charged residues; red,
negative charged residues). The enlargement shows the position of residues E66, W169, W172, and R374.
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including residues 168–174 in the modeled structure are slightly
shifted toward the domain interface relative to the ones in the
W169S/W172S mutant crystal structure, the overall conformation
of modeled structure is nearly identical to the crystal structure of
the mutant with an r.m.s.d. of 0.579 Å (Appendix Fig S12). We
then used the modeled structure of apo wild-type UgpB for the
further structural analysis and comparison.
Upon binding of G3P, UgpB’s conformation is locked in a closed
form via extensive interactions between G3P and both domains of
UgpB including residues E66,W169, W172, and R374 (Wuttge et al,
2012); in the absence of G3P, the structures of individual domains
are very similar to those found in the G3P-bound form
(Appendix Fig S13A), while the overall structure of UgpB undergoes
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domain relative to the other by ~21° (Fig 5A and Appendix Fig
S13B). Most interestingly from the perspective of chaperone activa-
tion, a deep continuous groove with a solvent-accessible volume of
940 Å3 at the domain interface is exposed to the solvent in the apo
form (Fig 5B). This groove, which is closed in the holo form,
exposes a number of hydrophobic residues (Met10, Leu14, Tyr42,
Tyr65, Val67, Trp169, Trp172, Ala 246, G249, Ala252, Gly 283,
Gly284, Tyr 323, and Pro371), most notably Trp169 and Trp172.
These two tryptophan residues when replaced by Ser result in no
G3P binding (Wuttge et al, 2012) and constitutive but lower chaper-
one activity (Fig 4G and H). In addition to hydrophobic residues,
the groove comprises some polar residues (Ser9, Ser121, Thr233,
Ser247, Ser250, and Thr321) and a few charged residues (Glu66 and
Arg374) (Fig 5B). Notably, many of these solvent-exposed residues,
including Tyr42, Glu66, Ser121, Trp169, Trp172, Gly284, Tyr323,
and Arg374, directly associate with G3P in the closed form (Wuttge
et al, 2012). To further examine if this solvent-exposed groove is of
sufficient size to accommodate polypeptide segments, we performed
computational docking using the MDockPrp server (Xu et al, 2018).
We attempted to dock a set of 24 different MDH peptides onto the
structure of apo UgpB. Strikingly, for all the tested peptides the
lowest energy docking score was into the groove (Fig EV3A). More-
over, among the top 10 predicted models for all peptides, 229/240
(95%) of the docking results show the peptides docked into the
same groove. In contrast, when we attempted to dock the peptides
onto the holo UgpB structure, the best docking energy scores placed
the peptides at various places around the surface of UgpB
(Fig EV3B) and the docking energies were all higher than docking
onto the apo wild-type UgpB structural model (Dataset EV2). Our
structural analysis and docking simulation suggest that the continu-
ous groove between the two domains in the apo UgpB structure
may comprise at least part of a putative binding site for unfolded
substrates.
Transition from acidic to neutral pH strips G3P and activates
UgpB’s chaperone activity
Our results suggest that UgpB only exhibits chaperone activity
against bile salt-induced protein unfolding when UgpB is G3P free.
We wondered how this requirement might possibly be linked to bile
salt expose, which most commonly takes place in the small intestine
of mammals. We know that when bacteria pass through the stom-
ach, they are exposed to an acidic environment (pH 1–3). Since
acidic conditions unfold proteins, including UgpB (Fig 6A; Goto
et al, 1990), we hypothesized that passage through the stomach
might strip G3P from UgpB and hence activate its chaperone activ-
ity. To test what will likely happen to UgpB upon exposure of bacte-
ria to stomach acid followed by their transition to the pH neutral
duodenum, we exposed UgpBG3P to pH 2 for 20 min and subse-
quently shifted the protein to pH 7 (see Materials and Methods). We
then determined the G3P content of the UgpB by adding G3P and
following tryptophan fluorescence (Fig 6B). Using this assay, we
determined that UgpB indeed loses its bound G3P following acid-
mediated denaturation. Consistently, we observed that the chaper-
one activity of UgpB is activated by the transition from pH 2 to 7
and that the addition of G3P can again inactivate the chaperone
function of UgpB (Fig 6C). We then examined whether G3P can
compete for client binding to UgpB. We found that addition of G3P
enhances the aggregation of CHO-induced MDH in a dose-dependent
manner (Figs 6D and EV2). These results strongly suggest that G3P
can compete with client proteins for UgpB’s binding, suggesting that
UgpB’s G3P binding and chaperone activities are likely mutually
exclusive activities.
Discussion
To gain access to the intestinal tract, enteric bacteria, such as E. coli,
must survive both the highly acidic environment of the stomach and
also must be resistant to high levels of bile salts to which they are
exposed to in the duodenum. These conditions present challenges
both to bacterial proteins and to the chaperones that are there to
protect them. Periplasmic proteins are particularly vulnerable to
these changing conditions because the outer membrane contains
pores, leaving the periplasm essentially unbuffered and vulnerable
to molecules smaller than ~600 Da, including protons and bile salts,
both of which are effective protein denaturing agents (Baba et al,
2006; Cremers et al, 2014; Lai et al, 2017). Increasing the challenge
to periplasmic chaperones is the complete lack of ATP in this
compartment; ATP is a cofactor that plays a key role in modulating
the activity and substrate-binding affinity of many chaperones
(Olive et al, 2007; Hartl et al, 2011; Midgett et al, 2017). The
absence of ATP in the periplasm has forced evolution to come up
with alternative mechanisms that periplasmic chaperones use to
govern their activity. One periplasmic chaperone, HdeA, is activated
by acid both transcriptionally and directly at the protein level. Low
pH acts to partially unfold and activate HdeA, which then tightly
binds its substrates, preventing their aggregation. Neutralization is
◀ Figure 6. pH transition can activate UgpB’s chaperone activity.A Acid denatures UgpB. The secondary structure of 2 lM UgpB was monitored by circular dichroism (CD) spectroscopy in 10 mM sodium phosphate buffer at pH 2 and
pH 7.
B G3P binds to acid-stripped UgpB as observed by monitoring the tryptophan fluorescence spectrum, either at pH 7 or after transition from pH 2 to 7 (see Materials
and Methods). Transitions from pH 2 to 7 in the presence of G3P are accompanied by a blue shift, indicating G3P binding.
C The anti-aggregation activity of UgpB is monitored by CHO-induced MDH aggregation assay. Light scattering values were monitored. The anti-aggregation activity of
UgpB is activated after transition from pH 2 to 7, and the addition of G3P (120 lM) can again inactivate its chaperone activity.
D Addition of G3P to UgpB inhibits its anti-aggregation chaperone activity. 12 lM of MDH and a 1:1 ratio of UgpB:MDH were used in a CHO-induced aggregation assay.
At 30 min, the indicated concentrations of G3P were added to solutions containing MDH, and MDH aggregation was monitored by light scattering. Note that G3P
binding to UgpB still occurs in the presence of 15 mM CHO as monitored by tryptophan fluorescence (inset and Appendix Fig S9).
Data information: These experiments were repeated twice with similar results, and one representative is shown.
Source data are available online for this figure.
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followed by substrate release and refolding of both the client and
the chaperone (Tapley et al, 2010). Another periplasmic chaperone,
Spy, finely tunes its affinity for client proteins to enable them to fold
while bound to Spy (Stull et al, 2016). This folding buries hydropho-
bic residues, decreasing client binding and helping favor client
release (Koldewey et al, 2016). Here, we show UgpB is a periplas-
mic chaperone capable of inhibiting bile-mediated protein aggrega-
tion and its chaperone activity is tightly regulated by the small
molecule G3P.
Our chaperone discovery efforts used a protein folding biosen-
sor-containing E. coli strain to find host factors involved in stabiliz-
ing destabilized variants of the well-studied model protein Im7.
Using this approach, we found that the UgpB serves as a molecular
chaperone to prevent generalized bile-induced protein aggregation.
UgpB’s previously characterized function is that as a periplasmic
G3P-binding protein (Wuttge et al, 2012). We report here that UgpB
has an additional moonlighting activity namely that as a molecular
chaperone. Of note, chaperone activity of various bacterial periplas-
mic substrate-binding proteins, including maltose-binding protein
(MBP), galactose-binding protein (MglB), oligopeptide-binding
protein (OppA), and dipeptide-binding protein (DppA), has previ-
ously been observed, implying that at least several small molecule
binding proteins may also play a role in protein stability (Richarme
& Caldas, 1997; Lennon et al, 2015). Among these binding proteins,
E. coli MBP is very commonly fused to recombinant proteins to
enhance their solubility and yield (Riggs, 2000). How MBP increases
the solubility of the fused protein is still not clear, but one possible
explanation is that MBP exerts a cis acting chaperone function when
fused to proteins (Richarme & Caldas, 1997; Fox et al, 2001). Inter-
estingly, mutations in the ligand-binding cleft of MBP can dramati-
cally reduce its ability to keep its fusion partner soluble (Fox et al,
2001). Though the chaperone active regions of OppA and DppA
have not yet been characterized, the co-crystal structure of OppA
and DppA with their substrate peptides shows that the peptide is
bound in a deep groove in the cleft region (Dunten & Mowbray,
1995; Sleigh et al, 1999).
UgpB appears to have the unusual ability to be able to broadly
target bile-induced protein aggregation. Though it has been
reported that chaperones are induced by bile salts (Flahaut et al,
1996; Bernstein et al, 1999; Leverrier et al, 2003; Ruiz et al, 2013;
Cremers et al, 2014), their role in combatting bile-induced protein
folding had been little studied. We find that none of the well-
studied periplasmic chaperones, including SurA, Spy, and OsmY,
are capable of inhibiting bile salt-induced protein aggregation.
Several studies highlight the role that bile salts play both in
bacterial stress and as environmental cues for signal transduction.
One recent study shows that bile salts are involved in virulence
gene regulation Vibrio cholera. Bile salt-mediated denaturation of
the transmembrane transcription factor ToxR enhances its ability
to interaction with its regulatory protein ToxS triggering activa-
tion of virulence gene expression (Midgett et al, 2017). In addi-
tion, bile salt binding to the IpaD needle tip of type III secretion
apparatus in Shigella flexneri has been shown to induce a confor-
mational change that results in the recruitment of IpaB which is
necessary for the maturation of the complex prior to host cell
contact (Dickenson et al, 2011). These are some positive ways
that bile salts induce structural changes, but overall bile salts are
damaging to proteins, making it not unsurprising that organisms
have evolved proteins like UgpB that respond to the threat these
potent protein denaturants pose.
Interestingly, it appears that UgpB only functions as a chaperone
when it is G3P free. Our structural analysis shows that a deep
groove opens up in UgpB when G3P dissociates, and consequently,
many residues of the core region, including the residues directly
associated with G3P interaction, are solvent-exposed. Mutational
studies show that UgpB variants of E66A and R374V, which are
defective in G3P binding, function as a constitutively active chaper-
ones. In addition, the two hydrophobic residues, W169 and W172,
are involved in G3P binding and likely also in peptide binding
(Wuttge et al, 2012), and our results suggest that they are also
involved in the chaperone activity of UgpB. Therefore, we propose
that G3P and peptides bind to sites on UgpB that at least partially
overlap. The overlap of G3P- and substrate-binding sites could
explain why the chaperone activity of UgpB is negatively regulated
by G3P binding.
We demonstrate that pH values that mimic those present in the
stomach serve to strip off bound G3P, activating UgpB as a chaper-
one uniquely capable of suppressing bile salt-mediated aggregation
of a broad variety of periplasmic proteins. This leads us to speculate
that a novel ATP-independent cycle exists whereby UgpB uses small
molecules present in various intestinal compartments to mediate
switching between G3P and chaperone activity in concert with
organismal needs. This model is illustrated in Fig EV4. Our experi-
ments suggest that stomach acid would likely strip off its bound
cofactor, exposing a deep groove on the surface of UpgB. This
would likely conveniently activate UgpB as a chaperone apparently
just in time for it to respond to the protein aggregation effects of
high concentrations of bile that flow into the duodenum, which is
the next stop in the journey of an organism through the intestinal
tract. These protein denaturation effects of bile however are a
temporary issue since as organisms pass into the jejunum, bile salts
are diluted out and efficiently absorbed (Heaton, 1969; Weski &
Ehrmann, 2012). As this is happening, the degradation of dietary
glycerophospholipids acts to raise G3P levels in the intestine (Wan-
ner, 1996; Ildiko Domonkos & Gombos, 2015; Blanco & Blanco,
2017). In the final steps in our proposed model, G3P produced by
digestion then binds to UgpB and inactivates its chaperone activity
(Fig EV4) and UgpB simultaneously regains its role as a G3P-
binding protein, allowing G3P to be used as a carbon and phosphate
source (Wanner, 1996).
Materials and Methods
Bacterial strains, growth conditions, and plasmid constructions
The strains used in this study are listed in Appendix Table S1. All
strains used are derivatives of E. coli K-12. The strain SQ765
(MG1655 DhsdR) was used as wild-type. The Tn5 insertions or dele-
tion alleles from the systematic Keio knockout strain collection were
transferred into the MG1655 wild-type strain by P1 transduction as
previously described (Lennox, 1955; Baba et al, 2006). To make
multiple gene deletions, the protocol of Baba et al was followed
(Baba et al, 2006). In brief, the single kanamycin insertion mutants
were transformed with pCP20, a plasmid encoding a temperature-
sensitive flippase, which was used to remove the kanamycin-
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resistant cassette from the chromosome, generating a kanamycin-
sensitive deletion (Baba et al, 2006). Subsequently, additional kana-
mycin-resistant gene insertions were transferred by P1 transduction.
NEB10b was used for cloning and maintaining of plasmids. If not
otherwise specified, cells were grown at 37°C in Luria–Bertani (LB)
broth containing appropriate antibiotics, 100 lg/ml ampicillin,
25 lg/ml kanamycin, 34 lg/ml chloramphenicol, and/or 17 lg/ml
tetracycline. The ugpB gene was cloned into pBAD33 and pTrc99a
for use in in vivo complementation (Appendix Table S1). For purifi-
cation purposes, the ugpB gene was cloned into pET28a-Sumo and
transformed into BL21(DE3). Site-directed mutagenesis was
performed as described (QuikChange Site-Directed Mutagenesis
Kit—Agilent). Primers and the restriction enzymes used for cloning
are described in Appendix Table S2.
Tn-Seq
Transposon mutagenesis was conducted as described by Lai et al
(2017). In brief, SQ765 pBR322, SQ765 pBR322 bla::Im7 L53A I54A,
SQ1698 pBR322, and SQ1698 pBR322-bla::Im7 L53A I54A were
mutagenized with the Ez-Tn5 < Kan-2 > transposome (Epicentre).
Transposon insertion mutants were isolated by selecting for kana-
mycin resistance on LB-Kan agar plates at 37°C. Between 7 × 105
and 106 colonies were pooled from the LB-Kan plates and suspended
in LB broth. Sterilized glycerol was added to the suspension
(OD600 = ~80) to a final concentration of 16%. The mutant library
was stored at 80°C. 140 ll of the mutant library cell stock was
inoculated into 50 ml of LB broth and cultured at 37°C with shaking
until the OD600 = ~1. The library cells were then plated on LB agar
with the indicated ampicillin concentrations (as described in the fig-
ure legends) and incubated at 37°C for 16 h. The colonies that arose
on these LB-ampicillin plates were harvested by scraping and
suspended in LB broth.
Tn-seq sequencing libraries were prepared as previously
described (Lai et al, 2017). Genomic DNA was extracted from the
pooled mutant slurry using the Wizard Genomic DNA Purification
Kit (Promega) and fragmented using NEBNext dsDNA Fragmentase
(NEB) at 37°C for 25 min. Afterward, fragmented DNA was purified
by using Agencourt AMPure XP beads (Beckman Coulter, Inc.) and
eluted into water. Purified fragmented DNA was treated with termi-
nal deoxynucleotidyl transferase (TdT; Promega) in a reaction with
dCTP and ddCTP to add poly-dC at the 30 end of DNA at 37°C for
1 h. TdT was then inactivated at 75°C for 20 min. TdT-treated DNA
was purified using a DTR gel filtration cartridge (EdgeBio).
The purified TdT-treated DNA was used as a template for PCR
amplification of the transposon junctions by using the Easy-A HiFi
Cloning System (Agilent Technologies) and the primers PolyG-1st-1
and Tn5-1st-1 (listed in Appendix Table S2). To amplify the trans-
poson junctions and append the sequencing barcode, a second
nested PCR was performed. NEBNext Multiplex Oligos for Illumina
(NEB) and Tn5-2nd-1 were used as primers. The final PCR product
was electrophoresed on a 2% agarose gel, and fragments ranging
from 200 to 500 bp were cut out and gel purified by using a
QIAquick Gel Extraction Kit (Qiagen). The purified libraries were
sequenced at the University of Michigan Sequencing Core on a
HiSeq 2500 (Illumina) on a single end run.
Sequenced reads were mapped to the E. coli MG1655 genome
(NCBI NC_000913). The transposon insertion sites were localized
and visualized by using the Sanger Artemis Genome Browser and
Annotation tool. The fold change enrichment under ampicillin selec-
tion conditions relative to LB without ampicillin was calculated as
previously described (Lai et al, 2017).
Spot titer assays
Colonies of wild-type and mutant strains were picked from LB plates
containing the appropriate antibiotics and then grown overnight in
LB broth also containing appropriate antibiotics with shaking at
37°C. Overnight cultures were diluted 100-fold in LB broth and incu-
bated with shaking at 37°C until the OD600 reached 1.0. For ugpB
complementation from either pBAD30 or pTrc99a vectors (Guzman
et al, 1995), 0.2% L-arabinose and 0.2 mM IPTG were added to
induce expression of UgpB from pBAD33 and pTrc99A, respectively,
when the culture OD600 reached 0.3–0.4; incubation continued until
the OD600 reached 1.0. The cells were diluted 10-fold in the range of
101 to 106, and 3 ll was spotted onto LB plates containing dif-
ferent concentrations of ampicillin. For ugpB complementation, 2%
L-arabinose or 0.2 mM IPTG supplementation in the LB agar
medium was used for the strains containing pBAD33 derivatives
and pTrc99a derivatives, respectively. The spotted plates were incu-
bated at 37°C for 12–14 h.
Western blotting
To monitor the levels of b-lactamase and its folding biosensor fusion
derivatives, single colonies of strains containing these constructs
were grown overnight in LB broth supplemented with the appropri-
ate antibiotics (17 lg/ml tetracycline) at 37°C, diluted 100-fold into
LB broth, and incubated to reach OD600 1.0 at 37°C. The harvested
cells were resuspended in PBS, disrupted by sonication using Kontes
micro ultra sonication cell disruptor on ice, followed by sonication
for three cycles of 5 s on ice. The resulting cell lysates were used for
Western blotting.
To monitor the levels of the Im7 and Im7 L53A I54A proteins
by themselves in the absence of a fusion context, single colonies
of strains containing plasmids expressing these strains were inocu-
lated in LB broth with appropriate antibiotics (25 lg/ml kana-
mycin) and incubated at 37°C overnight. The overnight culture
was diluted 100-fold in the LB broth and incubated at 37°C until
the cell culture reached an OD600 = 0.4. Im7 expression was then
induced by 5 mM IPTG for 1 h, and a periplasmic extract was
performed as previously described (Quan et al, 2011, 2013). These
cell extracts were subjected to SDS–PAGE (Nu-PAGE, Invitrogen)
and subsequently blotted onto a polyvinylidene difluoride
membrane (Trans-blot Turbo, Bio-Rad). Transferred membranes
were incubated in blocking solution (1× Tris-buffered saline (TBS)
pH 7.4, 0.01% Tween 20, 5% bovine serum albumin) for 1 h at
room temperature and then incubated with antibodies at 4°C over-
night. Anti-b-lactamase antibody (Millipore, AB-3738) and anti-
Im7 (lab collection, Pacific Immunology, Appendix Fig S14) were
used, with anti-maltose-binding protein (MBP; New England
Biolabs, E8032S) serving as a loading control. After washing with
1× Tris-buffered saline (TBS) pH 7.4, 0.01% Tween 20 (washing
buffer), secondary antibodies (IRDye 680LT goat anti-rabbit/
800CW goat anti-mouse, LI-COR) were added and allowed to bind
for 2 h at room temperature. The membranes were then washed
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with washing buffer and visualized by using the LI-COR imaging
system.
Periplasmic extraction
Periplasmic extracts were performed using the polymyxin B method
as described previously (Quan et al, 2013). Briefly, 4 OD600 units of
cells were harvested and resuspended in 100 ll of polymyxin buffer
(50 mM Tris HCl, pH 7.5, 5 mM EDTA, 150 mM NaCl, 1 mg/ml
polymyxin B sulfate). The cell resuspensions were incubated on ice
for 1 h and centrifuged at 16,000 g for 30 min at 4°C. The super-
natant served as the periplasmic fraction.
b-lactamase assay
To monitor b-lactamase activity in vitro, the strains harboring
expression vectors encoding Im7 L53A I54A fused b-lactamase
constructs (CL198, CL248, CL249, and CL250) were streaked on LB
agar plates containing 17 lg/ml tetracycline. Single colonies of
these strains were used to inoculate 5 ml 37°C overnight cultures in
LB broth containing 17 lg/ml tetracycline, diluted 100-fold in LB
broth, and incubated at 37°C until the OD600 reached 1.0. Harvested
cells were either resuspended in 50 mM sodium phosphate buffer
pH 6.0 and disrupted by sonication on ice or fractionated to obtain
periplasmic fractions.
For the activity assays, 4 lg of the periplasmic extracts were
diluted into 90 ll of 50 mM sodium phosphate buffer pH 6.0, and
5 ll of a 0.5 mM nitrocefin stock solution (Millipore) was added.
Hydrolysis of the b-lactamase substrate nitrocefin was detected by
the increase in absorbance at 486 nm over time using a 96-well
plate reader at 37°C. b-lactamase activity was normalized to the
activity of b-lactamase present in the parental CL198 strain.
Proteome analysis
CL198, CL248, and CL249 strains were streaked on LB agar plates
containing tetracycline. Single colonies of these strains were grown
overnight in LB broth with tetracycline at 37°C, then diluted 100-
fold into LB broth, and incubated at 37°C until the OD600 reached
1.0. 40 ml of these late log phase cells was then harvested by
centrifugation at 3,000 g for 10 min. The cell pellets were washed
twice in 40 ml of phosphate-buffered saline (137 mM NaCl, 2.7 mM
KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4). The cell pellets
were frozen in liquid nitrogen and then stored at 80°C. The cell
pellets were provided to MS Bioworks (Ann Arbor), who performed
mass spectroscopy analysis as described (Yan et al, 2019).
Protein purification
UgpB was purified as described previously (Quan et al, 2011).
Protein denaturation and renaturation
To remove tightly bound cofactors, purified UgpB was subjected to
a denaturation/renaturation procedure (Wuttge et al, 2012). UgpB
was dialyzed against 1 l of denaturing buffer (50 mM Tris HCl pH
7.5, 10 mM DTT, 6 M guanidine hydrochloride) overnight at 4°C.
UgpB was then renatured by dialysis against 1 l of renaturing buffer
(50 mM Tris HCl, pH 7.5) over 4 days, with two buffer changes per
day. The renatured proteins were exchanged into 40 mM HEPES pH
7.5 by five cycles of concentration and dilution with 10 kDa cutoff
Amicon centrifugal filter columns.
Isothermal titration calorimetry
All protein samples were dialyzed against a common solution of
40 mM HEPES KOH, pH 7.5. Isothermal titration calorimetry (ITC)
was performed with a MicroCal iTC200 using the same buffer at
10°C. 40 lM of UgpBG3P/apo UgpB was titrated with 400 lM G3P.
1.0 ll injections were used for the titrations. ITC thermograms were
fitted to a one-site model with the Origin software that is provided
with the instrument.
Circular dichroism
Far-UV circular dichroism (CD) spectra were recorded from 200 to
250 nm at 25°C in a Jasco J-1500 spectropolarimeter. To monitor
conformational changes due to G3P binding, the CD spectra of
10 lM UgpB and UgpBG3P in 50 mM sodium phosphate buffer at pH
6.0 were compared. The spectra of 2 lM UgpB incubated in 10 mM
sodium phosphate buffer at pH 2.0 or 7.0 were compared to monitor
acid-dependent denaturation.
Fluorescence emission spectra of tryptophan
UgpB has eight tryptophan residues. 2 lM of UgpB was used to
monitor the fluorescence emission spectra of tryptophan. 40 mM
HEPES pH 7.5 buffer was used to monitor G3P binding after renatu-
ration. 40 mM KH2PO4 KOH pH 7.5 buffer was used to monitor G3P
binding in the presence of bile salts and during the pH transition
simulation. Tryptophan fluorescence was excited at 295 nm, and
emission spectra were recorded from 300 to 400 nm at 25°C using a
Cary Eclipse fluorescence spectrophotometer.
Aggregation assays
CHO-induced aggregation was monitored by light scattering at 37°C.
12 lM MDH (Roche) was used in 40 mM KH2PO4 KOH pH 7.5
buffer containing 15 mM CHO. Light scattering was monitored at
360 nm using a Cary Eclipse fluorimeter in the absence or presence
of increasing concentrations of UgpB.
Protein supernatant/pellet assay for bile-induced
protein aggregation
Bile salt-induced protein aggregation was monitored by a super-
natant/pellet assay. 12 lM MDH (Roche), 12 lM CS (Sigma),
12 lM LDH (Roche), or 800 lg soluble total lysate from the SQ765
strain was used. 15 mM CHO (Sigma) was used for MDH and CS,
and 50 mM CHO was used for LDH and total lysate. 40 mM KH2PO4
KOH pH 7.5 was used for the CHO aggregation assay. Different
ratios of UgpB or MBP proteins were added as described. To deter-
mine the effect of G3P binding to UgpB, 120 lM of G3P was added
to the reaction buffers of MDH and LDH, and 60 and 600 lM of G3P
were added to the reaction buffers of CS and total lysate, respec-
tively. G3P was added before adding either UgpB or MBP into the
14 of 17 The EMBO Journal 39: e104231 | 2020 ª 2020 The Authors
The EMBO Journal Changhan Lee et al
buffer. Aggregation reactions were performed at 37°C for the
described time. After incubation, the samples were centrifuged at
16,000 g for 20 min at 4°C to separate supernatant and pellet frac-
tions. The pellet was washed with ice cold distilled water and centri-
fuged again at 16,000 g for 20 min at 4°C. The pellet was
resuspended in SDS–PAGE protein sample buffer, which is 5-fold
concentrated for MDH and CS and 10-fold concentrated for LDH and
total lysate. Both supernatant and pellet fractions were analyzed by
SDS–PAGE and visualized by Coomassie staining.
pH transition experiment
3 mM of UgpBG3P was incubated with 3 mM G3P for 5 min at
room temperature to allow for complete ligand binding. The incu-
bated UgpBG3P was added to 10 ml of either 10 mM NaH2PO4
HCl pH 2.0 or 10 mM NaH2PO4 NaOH pH 7.0 to attain a final
protein concentration of 5 lM and then kept at room temperature
for 20 min. To flush the released G3P, buffer was exchanged four
times by centrifuging at 2,800 g at room temperature using
Amicon 3 kDa cutoff centrifugal tubes. 100× stock (1 M NaH2PO4
NaOH pH 7.0) was added to neutralize pH 2.0 to pH 7.0. Buffer
was exchanged with 10 mM NaH2PO4 NaOH pH 7 by centrifuging
at 3,500 rpm at room temperature using Amicon 30 kDa cutoff
centrifugal tubes. The proteins were centrifuged at 16,000 g for
20 min at 4°C, and the soluble supernatant fraction was used to
monitor G3P binding by observing tryptophan fluorescence upon
addition of G3P.
Crystallization and structure determination
The microcrystals were initially obtained at 20°C by sitting-drop
vapor diffusion with 1 ll of 90 mg/ml UgpB (W169S/W172S) mixed
with an equal volume of reservoir solution containing 100 mM
CHES (pH 7.5) and 30% PEG400. A 2-ll drop containing microcrys-
tals of UgpB was diluted into a 50-ll mother reservoir solution,
vortexed with the stainless steel beads (Hampton), and then 1,000-
fold diluted to the mother reservoir solution to obtain the seed
stock. Well-diffracting crystals were grown at 20°C by hanging-drop
vapor diffusion with 1.5 ll of 90 mg/ml UgpB (W169S/W172S),
2 ll of the reservoir solution mentioned above, and 0.5 ll of seed
stock. Crystals were cryoprotected in the crystallization condition
supplemented with 25% glycerol and then flash-cooled in liquid
nitrogen.
The diffraction data were collected at beamline X06DA-PXIII at
the Swiss Light Source (SLS) and were processed using XDS. The
structure was solved by molecular replacement using PHENIX MR
with individual domains (N-terminal domain including residues 1–
122 and 282–359, and C-terminal domain including residues 123–
281 and 360–415) of the G3P-bound structure (pdb: 4aq4) as search-
ing models. Multiple rounds of manual model rebuilding and refine-
ment of the structure were carried out in Coot and PHENIX Refine
program. Statistics of X-ray structure determination are listed in
Appendix Table S3.
Protein-peptide docking
The docking experiments were performed with UgpB and 24 MDH
peptides using MDOCKPEP server (http://zougrouptoolkit.
missouri.edu/mdockpep/; Xu et al, 2018). Sequence of MDH
peptides used in this work can be found in Dataset EV2. The default
values of parameters were used in the docking simulation.
Data availability
The coordinates and structure factors for the UgpB structure have
been deposited in the Protein Data Bank (http://www.pdb.org)
under accession number 6X84.
Expanded View for this article is available online.
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